← back to search

Yanni Song

Houston Methodist · US
Area of research
Biomedical Engineering · Cancer Research
Research interest
Research interests include Medicine, Breast cancer, Cancer research, Colorectal cancer, Oncology, and Internal medicine.
h-index
citations
929
works
33
NIH funding
primary concept
email

Recent publications

Biomimetic Organic Nanozyme as Tumor Vaccines for Targeted Suppression of Ammonia‐Induced T Lymphocyte Death to Augment Breast Cancer Immunotherapy
Advanced Science 2025cited by 7position: lastdoi
CRISPR-dCas9-Mediated PTEN Activation via Tumor Cell Membrane-Coated Nanoplatform Enhances Sensitivity to Tyrosine Kinase Inhibitors in Nonsmall Cell Lung Cancer
ACS Applied Materials & Interfaces 2025cited by 5position: middledoi
Integrating ctDNA Dynamics and Sequential Organoid Drug Screening Enhances Breast Cancer Treatment Efficacy
Cancer Research 2025cited by 3position: middledoi
Single-cell and bulk transcriptomics reveal Fusobacterium nucleatum promotes colorectal cancer metastasis by upregulating LAMC2 in in vitro and in vivo models
Scientific Reports 2025cited by 1position: middledoi
Rising rainfall intensity induces spatially divergent hydrological changes within a large river basin
Nature Communications 2024cited by 80position: middledoi
Melanin-based duplex Cas9 ribonucleoprotein nanomedicine for synergistic phototherapy and immunotherapy
Chemical Engineering Journal 2024cited by 9position: middledoi
Hypoxia stimulates CTC-platelet cluster formation to promote breast cancer metastasis
iScience 2024cited by 8position: middledoi
Near-Infrared Titania Nanoparticle-Based Photoimmunotherapy via Tumor-Microenvironment-Responsive Gene Editing of SerpinB9 for Triple-Negative Breast Cancer
ACS Applied Nano Materials 2024cited by 4position: middledoi
Fusobacterium nucleatum upregulates MMP7 to promote metastasis-related characteristics of colorectal cancer cell via activating MAPK(JNK)-AP1 axis
Journal of Translational Medicine 2023cited by 43position: middledoi
Tumor Microenvironment-Responsive Nanoherb Delivery System for Synergistically Inhibition of Cancer Stem Cells
ACS Applied Materials & Interfaces 2023cited by 20position: middledoi
Characterization of endoplasmic reticulum stress unveils ZNF703 as a promising target for colorectal cancer immunotherapy
Journal of Translational Medicine 2023cited by 14position: middledoi
A Bidirectional Single‐Cell Migration and Retrieval Chip for Quantitative Study of Dendritic Cell Migration
Advanced Science 2023cited by 10position: middledoi
The tremendous clinical potential of the microbiota in the treatment of breast cancer: the next frontier
Journal of Cancer Research and Clinical Oncology 2023cited by 4position: lastdoi
Identification of the Crucial Role of CCL22 in F. nucleatum-Related Colorectal Tumorigenesis that Correlates With Tumor Microenvironment and Immune Checkpoint Therapy
Frontiers in Genetics 2022cited by 17position: middledoi
Tumor Microenvironment Heterogeneity-Based Score System Predicts Clinical Prognosis and Response to Immune Checkpoint Blockade in Multiple Colorectal Cancer Cohorts
Frontiers in Molecular Biosciences 2022cited by 14position: middledoi
A KRAS-Associated Signature for Prognostic, Immune and Chemical Anti-Cancer Drug-Response Prediction in Colon Cancer
Frontiers in Pharmacology 2022cited by 6position: middledoi
Correlation analysis between androgen receptor and the clinicopathological features and prognosis of mammary Paget’s disease
Journal of Cancer Research and Clinical Oncology 2022cited by 2position: lastdoi
DCTPP1, an Oncogene Regulated by miR-378a-3p, Promotes Proliferation of Breast Cancer via DNA Repair Signaling Pathway
Frontiers in Oncology 2021cited by 26position: middledoi
Silencing of PGK1 Promotes Sensitivity to Paclitaxel Treatment by Upregulating XAF1-Mediated Apoptosis in Triple-Negative Breast Cancer
Frontiers in Oncology 2021cited by 18position: middledoi
Long-term oncologic safety of immediate reconstructive surgery in patients with invasive breast cancer: a retrospective matched-cohort study
World Journal of Surgical Oncology 2021cited by 7position: firstdoi
N6-Methyladenosine Regulators Are Involved in the Progression of and Have Clinical Impact on Breast Cancer
Medical Science Monitor 2021cited by 5position: firstdoi
Diagnostic and prognostic role of NR3C4 in breast cancer through a genomic network understanding
Pathology - Research and Practice 2020cited by 7position: firstdoi
CRISPR-Cas12a Coupled with Platinum Nanoreporter for Visual Quantification of SNVs on a Volumetric Bar-Chart Chip
Analytical Chemistry 2019cited by 146position: middledoi
Androgen Receptor Expression and Bicalutamide Antagonize Androgen Receptor Inhibit β-Catenin Transcription Complex in Estrogen Receptor-Negative Breast Cancer
Cellular Physiology and Biochemistry 2017cited by 44position: middledoi
ATAD2 overexpression is associated with progression and prognosis in colorectal cancer
Japanese Journal of Clinical Oncology 2016cited by 30position: middledoi
Colorectal cancer stem cell and chemoresistant colorectal cancer cell phenotypes and increased sensitivity to Notch pathway inhibitor
Molecular Medicine Reports 2015cited by 60position: middledoi
Polymorphic CAG Repeat and Protein Expression of Androgen Receptor Gene in Colorectal Cancer
Molecular Cancer Therapeutics 2015cited by 33position: middledoi
Elevated expression of HABP1 is a novel prognostic indicator in triple-negative breast cancers
Tumor Biology 2015cited by 26position: middledoi
Unique clinicopathological features of metaplastic breast carcinoma compared with invasive ductal carcinoma and poor prognostic indicators
World Journal of Surgical Oncology 2013cited by 152position: firstdoi
Surgical Treatment of Gynecomastia
Annals of Plastic Surgery 2013cited by 22position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Rui Huang · Harbin Medical University11 papers (2015–2023)Da Pang · First People's Hospital of Foshan8 papers (2012–2025)Xin Han · Wenzhou Medical University7 papers (2019–2025)Suwen Ou · Ministry of Education of the People's Republic of China6 papers (2022–2025)Hufei Wang · The First Affiliated Hospital, Sun Yat-sen University6 papers (2022–2025)Zilong Guan · Harbin Medical University5 papers (2022–2023)Shanshan Sun · Shandong University5 papers (2013–2022)Songlin Ran · Harbin Medical University5 papers (2022–2025)Kangjia Luo · Ningbo University5 papers (2022–2023)Yangbao Tao · Harbin Medical University5 papers (2021–2023)Jinhua Ye · Fudan University5 papers (2022–2025)Yanlv Ren · Harbin Medical University4 papers (2012–2013)Guoqiang Zhang · First Affiliated Hospital of Hebei Medical University4 papers (2012–2025)Xiaoshuan Liang · Harbin Medical University4 papers (2013–2021)Jing Qian · Nanjing University of Chinese Medicine3 papers (2024–2025)Shan Yu · Peking University3 papers (2020–2023)Ming Niu · Harbin Medical University3 papers (2017–2021)Yinghu Jin · Harbin Medical University3 papers (2022–2023)Gaoyu Shi · Nanjing University of Chinese Medicine3 papers (2024–2025)Zhi Li · Dalian Medical University3 papers (2022–2023)